147 related articles for article (PubMed ID: 34348562)
21. Analysis and prediction of regrowth in benign thyroid nodules undergoing radiofrequency ablation: a retrospective study with a 5-year follow-up.
Li Y; Li W; Jiang B; Zhao J; Zhang Y; Luo Y
Eur Radiol; 2023 Aug; 33(8):5615-5624. PubMed ID: 36951983
[TBL] [Abstract][Full Text] [Related]
22. A Nomogram to Predict Regrowth After Ultrasound-Guided Radiofrequency Ablation for Benign Thyroid Nodules.
Yan L; Zhang M; Li X; Li Y; Luo Y
Front Endocrinol (Lausanne); 2021; 12():774228. PubMed ID: 35250847
[TBL] [Abstract][Full Text] [Related]
23. Long-term results of radiofrequency ablation for locally recurrent papillary thyroid carcinoma.
Yang Z; Yan L; Xiao J; Li W; Li X; Li Y; Zhang M; Luo Y
Int J Hyperthermia; 2023; 40(1):2191912. PubMed ID: 37164353
[TBL] [Abstract][Full Text] [Related]
24. Preoperative prognostic risk stratification model for papillary thyroid carcinoma based on clinical and ultrasound characteristics.
Shen K; Xiao S; Wu X; Zhang G
Front Endocrinol (Lausanne); 2022; 13():1025739. PubMed ID: 36277684
[TBL] [Abstract][Full Text] [Related]
25. Optimal thyrotropin level for low-risk papillary thyroid carcinoma after ultrasound-guided radiofrequency ablation.
Li X; Yan L; Xiao J; Li Y; Zhu Y; Yang Z; Zhang M; Luo Y
Int J Hyperthermia; 2023; 40(1):2160880. PubMed ID: 36599433
[TBL] [Abstract][Full Text] [Related]
26. A prognostic nomogram for papillary thyroid cancer lymph node metastasis based on immune score.
Lu Y; Qian K; Fei M; Guo K; Shi Y; Wang Z
Front Endocrinol (Lausanne); 2022; 13():993856. PubMed ID: 36531470
[TBL] [Abstract][Full Text] [Related]
27. Safety and efficacy of thermal ablation for cervical metastatic lymph nodes in papillary thyroid carcinoma: A systematic review and meta-analysis.
Tang W; Tang X; Jiang D; Zhang X; Wang R; Niu X; Zang Y; Zhang M; Wang X; Zhao C
Front Endocrinol (Lausanne); 2022; 13():967044. PubMed ID: 36072932
[TBL] [Abstract][Full Text] [Related]
28. Nomogram to predict the risk of biochemical recurrence and structural recurrence in patients with stage cN1 papillary thyroid carcinoma.
Ma T; Shi P; Ma T; Liang M; Wang L; Shi Y
J Cancer Res Clin Oncol; 2023 Oct; 149(13):11073-11083. PubMed ID: 37340187
[TBL] [Abstract][Full Text] [Related]
29. Using Diffusion-Weighted MRI to Predict Central Lymph Node Metastasis in Papillary Thyroid Carcinoma: A Feasibility Study.
Zhang H; Hu S; Wang X; Liu W; He J; Sun Z; Ge Y; Dou W
Front Endocrinol (Lausanne); 2020; 11():326. PubMed ID: 32595598
[No Abstract] [Full Text] [Related]
30. A nomogram predicting contralateral central neck lymph node metastasis for papillary thyroid carcinoma.
Hei H; Song Y; Qin J
J Surg Oncol; 2016 Nov; 114(6):703-707. PubMed ID: 27634154
[TBL] [Abstract][Full Text] [Related]
31. Development and validation of a nomogram based on stromal score to predict progression-free survival of patients with papillary thyroid carcinoma.
Tang J; Jiang S; Gao Q; Xi X; Gao L; Zhao R; Lai X; Zhang B; Jiang Y
Cancer Med; 2021 Aug; 10(16):5488-5498. PubMed ID: 34240816
[TBL] [Abstract][Full Text] [Related]
32. Ultrasonography-guided radiofrequency ablation for solitary T1aN0M0 and T1bN0M0 papillary thyroid carcinoma: a retrospective comparative study.
Xiao J; Zhang Y; Yan L; Zhang M; Li X; Tang J; Luo Y
Eur J Endocrinol; 2021 Dec; 186(1):105-113. PubMed ID: 34757942
[TBL] [Abstract][Full Text] [Related]
33. Efficacy and safety of radiofrequency ablation in the treatment of low-risk papillary thyroid carcinoma: a review.
Ntelis S; Linos D
Hormones (Athens); 2021 Jun; 20(2):269-277. PubMed ID: 33822327
[TBL] [Abstract][Full Text] [Related]
34. Clinical value of matrix metalloproteinase-2 and -9 in ultrasound-guided radiofrequency ablation treatment for papillary thyroid carcinoma.
Pan Q; Yuan T; Ding Q
J Int Med Res; 2020 Aug; 48(8):300060520917581. PubMed ID: 32772889
[TBL] [Abstract][Full Text] [Related]
35. Radiofrequency ablation for papillary thyroid cancer located in isthmus: comparison with that originated in thyroid lobe.
Xiao J; Yan L; Li Y; Li X; Yang Z; Zhang M; Luo Y
Int J Hyperthermia; 2023; 40(1):2266668. PubMed ID: 37940133
[TBL] [Abstract][Full Text] [Related]
36. Ultrasonography-guided radiofrequency ablation for the treatment of T2N0M0 papillary thyroid carcinoma: a preliminary study.
Xiao J; Zhang Y; Zhang M; Xie F; Yan L; Luo Y; Tang J
Int J Hyperthermia; 2021; 38(1):402-408. PubMed ID: 33719861
[TBL] [Abstract][Full Text] [Related]
37. Efficacy and Safety of Thermal Ablation for Treatment of Solitary T1N0M0 Papillary Thyroid Carcinoma: A Multicenter Retrospective Study.
Cao XJ; Wang SR; Che Y; Liu J; Cong ZB; He JF; Wang HL; Liu G; Guo JQ; Hao Y; Wang ZH; Zhou Y; Jian M; Shi LL; Qi L; Zhu YL; Wang X; Yan GZ; Shataer A; Liu XF; Wei Y; Zhao ZL; Peng LL; Li Y; Yu MA
Radiology; 2021 Jul; 300(1):209-216. PubMed ID: 33904775
[TBL] [Abstract][Full Text] [Related]
38. Predictive nomograms of repeat intrahepatic recurrence and overall survival after radiofrequency ablation of recurrent colorectal liver metastases.
Wang JC; Jiang BB; Zhang ZY; Liu YH; Shao LJ; Wang S; Yang W; Wu W; Yan K
Int J Hyperthermia; 2024; 41(1):2323152. PubMed ID: 38465646
[TBL] [Abstract][Full Text] [Related]
39. Nomogram Based on Shear-Wave Elastography Radiomics Can Improve Preoperative Cervical Lymph Node Staging for Papillary Thyroid Carcinoma.
Jiang M; Li C; Tang S; Lv W; Yi A; Wang B; Yu S; Cui X; Dietrich CF
Thyroid; 2020 Jun; 30(6):885-897. PubMed ID: 32027225
[No Abstract] [Full Text] [Related]
40. Nomograms to Predict the Disease-free Survival and Overall Survival after Radiofrequency Ablation for Hepatocellular Carcinoma.
Takuma Y; Shota I; Miyatake H; Uematsu S; Okamoto R; Araki Y; Takabatake H; Morimoto Y; Yamamoto H
Intern Med; 2018 Feb; 57(4):457-468. PubMed ID: 29151504
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
